Dual role of lncRNA OTUD6B-AS1 in immune evasion and ferroptosis resistance: A prognostic and therapeutic biomarker in breast cancer
In conclusion, OTUD6B-AS1 serves as a biomarker in BC, driving immune evasion and ferroptosis resistance. Targeting OTUD6B-AS1 may enhance immunotherapy efficacy and overcome chemoresistance, offering novel therapeutic avenues.
Authors
- Shasha Liu (ORCID: https://orcid.org/0000-0002-7236-1716)
- Hong Liu (ORCID: https://orcid.org/0000-0002-3985-9504)
- Jianing Zhang (ORCID: https://orcid.org/0000-0002-9088-7965)
- Xirui Zhou (ORCID: https://orcid.org/0000-0002-4838-6729)
- Zi-Lu Yi
Institutions
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Non-coding RNA Research
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1016/j.ncrna.2025.06.002
- Citations
- 2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 1.87